Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

CyBio and MACHEREY-NAGEL Collaborate to Develop Applications for Automated DNA/RNA Preparation

Published: Tuesday, July 31, 2007
Last Updated: Monday, August 06, 2007
Bookmark and Share
The cooperation focuses on the automation of nucleic acid preparation from various biological sample materials and the purification of PCR products.

CyBio AG and MACHEREY-NAGEL GmH Co. KG have signed a non-exclusive collaboration for the joint development of applications to automate MACHEREY-NAGEL kits on CyBio liquid handling instruments.

The cooperation focuses on the automation of nucleic acid preparation from various biological sample materials and the purification of PCR products, e.g. for subsequent sequencing and cloning experiments. Due to continuous advancement of the brands NucleoSpin®, NucleoMag und NucleoFast, MACHEREY-NAGEL has gained a worldwide leading position in this field.

For CyBio the cooperation is a further milestone to strategically strengthen the company’s position in genomics. The CyBi®-GeneRobots product family has been designed for genomics applications and offers specific solutions for varying automation levels.

CyBi®-GeneRobots incorporate the well-known pipettors CyBi®-DiluSpro, CyBi®-Well vario, CyBi®-Genomics Workstation and CyBi®-RoboSpense.

The cooperation of both partners will enable the automation of MACHEREY-NAGEL’s DNA/RNA preparation kits with CyBio’s liquid handling instruments, addressing a broad range of customers with diverse demands regarding application, automation and throughput.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Spain’s Pharmaceutical Companies Trust in the Reliability of CyBio’s Liquid Handling
CyBio’s Spanish distribution partner Inycom will present CyBio’s products at the Farmameeting 2006 in Madrid.
Saturday, January 14, 2006
Scientific News
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
How Cell Growth Triggers Cell Division
Researchers in Jan Skotheim's lab have discovered a previously unknown mechanism that controls how large cells grow, an insight that could one day provide insight into attacking diseases such as cancer.
Microbe Sleuth
Tanja Bosak examines how life and the Earth evolved in tandem during their early history together.
3 Ways Viruses Have Changed Science for the Better
Viruses are really good at what they do, and we’ve been able to harness their skills to learn about – and potentially improve – human health in several ways.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos